Doncasters Group, the nearly 250-year-old British metal engineering firm and longtime supplier to Boeing (BA), is considering an initial public offering in New York, Bloomberg News reported Wednesday,

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 to $17 per share. | Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price between $15 and $17 per share.

According to a filing with the Securities and Exchange Commission dated October 20, 2025, Renaissance Capital reported a new stake in Circle Internet Group, purchasing 51,208 shares during the third quarter.

Doncasters Group, an almost 250-year-old UK metal engineering group that supplies Boeing, is exploring an initial public offering in New York to tap rising investor demand for civil and military aerospace suppliers,

OpenAI is considering filing with securities regulators as soon as the second half of 2026, people familiar with the matter said.

Navan just went public during the government shutdown, a risky move that sent its shares tumbling. Here's what investors' stakes are worth.

Explore the top IPO stocks to invest in, with expert tips on evaluating new public companies and how to invest to maximize your returns.

Navan's shares started trading 12% below their initial public offering price on Thursday, as the travel technology company faced choppy market conditions amid a prolonged U.S. government shutdown.

Three mainboard IPOs- Orkla India, Studds Accessories and Lenskart Solutions- are open for investors for primary market investments have seen mixed response.

Lenskart, India’s largest eyewear brand and among the top two players in Asia in the organized prescription eyeglasses segment (by B2C sales volume), has set its price band at Rs 382–Rs 402 per share.

Capital raising offers a chance to boost capital spending. Private investment has been stagnant at about 10% of GDP— disappointing given the government’s ambition that India be a developed country by 2047. Corporate-tax cuts in 2019 have failed to spur a revival. A planned deregulatory push may give firms more reason to spend.